Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Expert Opin Drug Discov. 2019 May 9;14(7):667–682. doi: 10.1080/17460441.2019.1613370

Table 1.

Newly reported HIF inhibitors

Inhibitor Mechanism of Inhibition
Benzopyranyl triazole (1) Increased HIF-1α hydroxylation
BIX01294 (2) Increased HIF-1α hydroxylation/HIF-1α protein degradation
Cardenolides (3) Decreased HIF-1 transcriptional activity
CRLX-101 (4) Decreased HIF-1α protein accumulation
EZN-2208 (5) Decreased HIF-1α protein expression and transcriptional activity
Glyceollins (6) Decreased HIF-1α translation/stability
IDF-1174 (7) Increased HIF-1α degradation
LBH589 (8) Increased HIF-1α degradation
MPT0G157 (9) Increased HIF-1α degradation
Vorinostat (10) Decreased HIF-1/2α translation/nuclear localization/stability
NNC 55–0396 (11) Decreased HIF-1α protein expression/translation/Increased HIF-1α hydroxylation
Kresoxim-methyl analogues (12) Decreased HIF-1α stability
PT2385 (13) and PT2399 (14) Decreased HIF-2 heterodimerization